Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording

Vincenzo Savarino, Giuseppe Sandro Mela, Patrizia Zentilin, Patrizia Scalabrini, Giuseppe Bonifacino, Patrizia Gambara, Guido Celle

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The effects of single daily doses of placebo, nizatidine 300 mg, ranitidine 300 mg and famotidine 40 mg, given at 22.00 h, have been compared in 16 patients with healed duodenal ulcers. Each of them underwent the above treatment on four separate occasions. The three H: receptor antagonists showed a significantly higher acid inhibition than placebo (p <0,003) throughout the whole 24-hour period. Famotidine turned out to be more effective than nizatidine (p <0.02) in reducing circadian acidity, while there was no differ-ence between ranitidine and nizatidine. The effects of the three Hi blockers on overnight acidity (from 23.00 to 07.00) were similar to each other, whereas both famotidine (p <0.003) and ranitidine (p <0.02) produced more anacidity than nizatidine during the morning hours (from 07.00 to 12.00). The time period elapsed in consecutive minutes above 5.0 pH units during drug-related events was significantly longer with both famotidine (p <0.01) and ranitidine (p <0.01) compared to nizatidine. Therefore in the recommended dosages for clinical use the acid suppression of nizatidine was significantly shorter-lasting than that of both ranitidine and famotidine. The major change is represented by the lack of carryover effect of nizatidine on morning acidity.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalDigestion
Volume42
Issue number1
DOIs
Publication statusPublished - 1989

Fingerprint

Nizatidine
Famotidine
Placebo Effect
Ranitidine
Placebos
Acids
Duodenal Ulcer

Keywords

  • Acid inhibition
  • Continuous
  • Famotidine
  • Nizatidine
  • pH-metry
  • Ranitidine

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Savarino, V., Mela, G. S., Zentilin, P., Scalabrini, P., Bonifacino, G., Gambara, P., & Celle, G. (1989). Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Digestion, 42(1), 1-6. https://doi.org/10.1159/000199818

Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. / Savarino, Vincenzo; Mela, Giuseppe Sandro; Zentilin, Patrizia; Scalabrini, Patrizia; Bonifacino, Giuseppe; Gambara, Patrizia; Celle, Guido.

In: Digestion, Vol. 42, No. 1, 1989, p. 1-6.

Research output: Contribution to journalArticle

Savarino, V, Mela, GS, Zentilin, P, Scalabrini, P, Bonifacino, G, Gambara, P & Celle, G 1989, 'Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording', Digestion, vol. 42, no. 1, pp. 1-6. https://doi.org/10.1159/000199818
Savarino, Vincenzo ; Mela, Giuseppe Sandro ; Zentilin, Patrizia ; Scalabrini, Patrizia ; Bonifacino, Giuseppe ; Gambara, Patrizia ; Celle, Guido. / Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. In: Digestion. 1989 ; Vol. 42, No. 1. pp. 1-6.
@article{45a2a70c8af24a8da2e798b18fc35dc7,
title = "Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording",
abstract = "The effects of single daily doses of placebo, nizatidine 300 mg, ranitidine 300 mg and famotidine 40 mg, given at 22.00 h, have been compared in 16 patients with healed duodenal ulcers. Each of them underwent the above treatment on four separate occasions. The three H: receptor antagonists showed a significantly higher acid inhibition than placebo (p <0,003) throughout the whole 24-hour period. Famotidine turned out to be more effective than nizatidine (p <0.02) in reducing circadian acidity, while there was no differ-ence between ranitidine and nizatidine. The effects of the three Hi blockers on overnight acidity (from 23.00 to 07.00) were similar to each other, whereas both famotidine (p <0.003) and ranitidine (p <0.02) produced more anacidity than nizatidine during the morning hours (from 07.00 to 12.00). The time period elapsed in consecutive minutes above 5.0 pH units during drug-related events was significantly longer with both famotidine (p <0.01) and ranitidine (p <0.01) compared to nizatidine. Therefore in the recommended dosages for clinical use the acid suppression of nizatidine was significantly shorter-lasting than that of both ranitidine and famotidine. The major change is represented by the lack of carryover effect of nizatidine on morning acidity.",
keywords = "Acid inhibition, Continuous, Famotidine, Nizatidine, pH-metry, Ranitidine",
author = "Vincenzo Savarino and Mela, {Giuseppe Sandro} and Patrizia Zentilin and Patrizia Scalabrini and Giuseppe Bonifacino and Patrizia Gambara and Guido Celle",
year = "1989",
doi = "10.1159/000199818",
language = "English",
volume = "42",
pages = "1--6",
journal = "Digestion",
issn = "0012-2823",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording

AU - Savarino, Vincenzo

AU - Mela, Giuseppe Sandro

AU - Zentilin, Patrizia

AU - Scalabrini, Patrizia

AU - Bonifacino, Giuseppe

AU - Gambara, Patrizia

AU - Celle, Guido

PY - 1989

Y1 - 1989

N2 - The effects of single daily doses of placebo, nizatidine 300 mg, ranitidine 300 mg and famotidine 40 mg, given at 22.00 h, have been compared in 16 patients with healed duodenal ulcers. Each of them underwent the above treatment on four separate occasions. The three H: receptor antagonists showed a significantly higher acid inhibition than placebo (p <0,003) throughout the whole 24-hour period. Famotidine turned out to be more effective than nizatidine (p <0.02) in reducing circadian acidity, while there was no differ-ence between ranitidine and nizatidine. The effects of the three Hi blockers on overnight acidity (from 23.00 to 07.00) were similar to each other, whereas both famotidine (p <0.003) and ranitidine (p <0.02) produced more anacidity than nizatidine during the morning hours (from 07.00 to 12.00). The time period elapsed in consecutive minutes above 5.0 pH units during drug-related events was significantly longer with both famotidine (p <0.01) and ranitidine (p <0.01) compared to nizatidine. Therefore in the recommended dosages for clinical use the acid suppression of nizatidine was significantly shorter-lasting than that of both ranitidine and famotidine. The major change is represented by the lack of carryover effect of nizatidine on morning acidity.

AB - The effects of single daily doses of placebo, nizatidine 300 mg, ranitidine 300 mg and famotidine 40 mg, given at 22.00 h, have been compared in 16 patients with healed duodenal ulcers. Each of them underwent the above treatment on four separate occasions. The three H: receptor antagonists showed a significantly higher acid inhibition than placebo (p <0,003) throughout the whole 24-hour period. Famotidine turned out to be more effective than nizatidine (p <0.02) in reducing circadian acidity, while there was no differ-ence between ranitidine and nizatidine. The effects of the three Hi blockers on overnight acidity (from 23.00 to 07.00) were similar to each other, whereas both famotidine (p <0.003) and ranitidine (p <0.02) produced more anacidity than nizatidine during the morning hours (from 07.00 to 12.00). The time period elapsed in consecutive minutes above 5.0 pH units during drug-related events was significantly longer with both famotidine (p <0.01) and ranitidine (p <0.01) compared to nizatidine. Therefore in the recommended dosages for clinical use the acid suppression of nizatidine was significantly shorter-lasting than that of both ranitidine and famotidine. The major change is represented by the lack of carryover effect of nizatidine on morning acidity.

KW - Acid inhibition

KW - Continuous

KW - Famotidine

KW - Nizatidine

KW - pH-metry

KW - Ranitidine

UR - http://www.scopus.com/inward/record.url?scp=0024559474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024559474&partnerID=8YFLogxK

U2 - 10.1159/000199818

DO - 10.1159/000199818

M3 - Article

C2 - 2568299

AN - SCOPUS:0024559474

VL - 42

SP - 1

EP - 6

JO - Digestion

JF - Digestion

SN - 0012-2823

IS - 1

ER -